Dolin Pj RM, 1994, Global tuberculosis incidence and mortality during 1990‐2000, Bull World Health Organ, 72, 213
10.1164/ajrccm.152.5.7582297
Colditz GA, 1995, The efficacy of bacillus Calmette‐Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta‐analyses of the published literature, Pediatrics, 96, 29, 10.1542/peds.96.1.29
Sterne JA, 1998, Does the efficacy of BCG decline with time since vaccination?, Int J Tuberc Lung Dis, 2, 200
Comstock GW, 1976, Tuberculosis studies in Muscogee County, Gerorgia. Twent‐year evaluation of community trial of BCG vaccination, Public Health Rep, 91, 276
10.1001/jama.1994.03510330076038
10.1016/S0140-6736(96)02166-6
10.1093/oxfordjournals.aje.a120672
10.1016/0041-3879(73)90026-3
Palmer CE, 1966, Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis, Am Rev Respir Dis, 94, 553
10.1128/IAI.70.2.672-678.2002
Leung CC, 2001, Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong, Int J Tuberc Lung Dis, 5, 717
Jassal M, 2008, Extensively drug‐resistant tuberculosis, Lancet Infect Dis
10.1016/j.vaccine.2005.01.060
10.1016/j.tube.2004.09.009
10.1128/CVI.13.2.179-186.2006
10.1016/S0264-410X(01)00436-4
10.1128/IAI.55.9.2037-2041.1987
10.4049/jimmunol.138.1.293
10.1016/0008-8749(84)90082-0
Pedrazzini T, 1987, Importance of L3T4+ and Lyt‐2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette‐Guerin in mice. Assessment by elimination of T cell subsets in vivo, J Immunol, 139, 2032, 10.4049/jimmunol.139.6.2032
10.1016/j.micinf.2005.03.011
10.1016/S1359-6101(00)00010-1
Frucht DM, 1996, Defective monocyte costimulation for IFN‐gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL‐12 regulation, J Immunol, 157, 411, 10.4049/jimmunol.157.1.411
10.1111/j.1462-5822.2004.00480.x
10.1056/NEJM199612263352604
10.1056/NEJM199612263352602
10.4049/jimmunol.171.9.4689
10.1016/j.trstmh.2004.08.006
10.1128/IAI.74.4.2128-2137.2006
10.4049/jimmunol.181.11.7948
10.1016/j.vaccine.2008.10.056
10.1371/journal.ppat.0010033
10.1128/JB.94.5.1736-1745.1967
10.1128/IAI.56.12.3310-3312.1988
10.1128/IAI.60.11.4781-4792.1992
10.1128/IAI.62.6.2536-2544.1994
Roberts AD, 1995, Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis, Immunology, 85, 502
10.1016/S1471-4906(01)01865-8
10.1016/0022-1759(93)90195-D
10.1128/IAI.61.3.844-851.1993
10.1128/IAI.63.4.1491-1497.1995
10.1128/IAI.67.11.5967-5971.1999
10.1128/IAI.65.7.2587-2592.1997
10.1128/IAI.57.10.3123-3130.1989
10.1016/S0962-8479(96)90029-5
10.1128/IAI.68.2.791-795.2000
10.4049/jimmunol.174.10.6332
10.4049/jimmunol.161.5.2356
10.1128/IAI.70.10.5446-5453.2002
10.1128/IAI.68.1.214-220.2000
10.1146/annurev.immunol.19.1.93
10.1111/j.1365-2567.2006.02355.x
10.1128/IAI.64.6.2062-2069.1996
10.1128/IAI.37.3.1042-1049.1982
10.1128/IAI.24.2.363-370.1979
10.1046/j.1365-2958.2003.03474.x
10.1128/IAI.73.5.3038-3043.2005
10.1046/j.1365-2958.2002.02779.x
10.4049/jimmunol.160.3.1290
10.4049/jimmunol.174.3.1491
10.1128/IAI.69.5.2773-2778.2001
10.4049/jimmunol.172.12.7618
10.1016/j.vaccine.2004.11.051
10.4049/jimmunol.178.6.3721
10.1128/IAI.72.11.6622-6632.2004
10.1371/journal.pone.0003683
10.1016/j.copbio.2004.09.001
10.4049/jimmunol.173.10.6357
10.4049/jimmunol.171.3.1602
10.1164/rccm.200809-1486OC
10.1128/JVI.62.5.1530-1534.1988
10.1016/0962-8479(94)90105-8
10.1128/IAI.68.3.1706-1709.2000
10.1128/IAI.70.7.3318-3323.2002
10.1128/IAI.71.4.2192-2198.2003
10.1016/j.vaccine.2005.05.035
10.1128/IAI.70.1.292-302.2002
10.4049/jimmunol.171.6.3110
10.1111/j.1469-0691.2007.01891.x
10.1016/S0140-6736(06)68507-3
10.7326/0003-4819-131-1-199907060-00007
10.1016/j.molmed.2007.03.004
10.1371/journal.pbio.0060311
